内分泌科指南

订阅

MedSci主页 / 所有栏目 / 内分泌科指南

2019 ADA/EASD共识：2型糖尿病患者高血糖的管理（更新版）

2019-12-19 美国糖尿病学会 Diabetes Care. 2019 Dec 19.

2型糖尿病高血糖

2019年12月，美国糖尿病学会(ADA)联合欧洲糖尿病研究协会(EASD)更新了2018版2型糖尿病患者高血糖的管理共识报告。主要更新内容包括3点。

中文标题：

2019 ADA/EASD共识：2型糖尿病患者高血糖的管理（更新版）

英文标题：

2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

发布机构：

美国糖尿病学会

发布日期：

2019-12-19

简要介绍：

2019年12月，美国糖尿病学会(ADA)联合欧洲糖尿病研究协会(EASD)更新了2018版2型糖尿病患者高血糖的管理共识报告。主要更新内容包括3点。

 

拓展指南：与糖尿病相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2019 ADA/EASD共识：2型糖尿病患者高血糖的管理（更新版）)] GetToolGuiderByIdResponse(projectId=1, id=bfa7f1c0018a46ad, title=2019 ADA/EASD共识：2型糖尿病患者高血糖的管理（更新版）, enTitle=2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)., guiderFrom=Diabetes Care. 2019 Dec 19., authorId=null, author=, summary=2019年12月，美国糖尿病学会(ADA)联合欧洲糖尿病研究协会(EASD)更新了2018版2型糖尿病患者高血糖的管理共识报告。主要更新内容包括3点。 , cover=, journalId=null, articlesId=null, associationId=54, associationName=美国糖尿病学会, associationIntro=美国糖尿病协会县美国重要的非赢利性卫生姐织，旨在提供有关糖尿病的研究进展和信息，促进糖尿病的科研、教育、诊疗等，关注一切与糖尿病有关的事务。协会成立千 1940年，以预防和治疗糖尿病，改善所有糖尿病患者生活质量为目标。一年一度的全球糖尿病领域最大规模的盛会&mdash;&mdash;美国糖尿病协会（ADA)年会于每年的6月如期而至，每年将有来自世界各地的13000名研究者、医生及其他专业人士莅临，共同分享糖尿病领域前沿研究、治疗建议以及治疗新趋势，聚焦糖尿病领域基础研究与临床实践的最新进展，公布最新临床试验结果，关注如何将研究成果应用于临床实践。, copyright=0, guiderPublishedTime=Thu Dec 19 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>2019年12月，美国糖尿病学会(ADA)联合欧洲糖尿病研究协会(EASD)更新了2018版2型糖尿病患者高血糖的管理共识报告。主要更新内容包括3点。 </P> <P> </P>拓展指南：<strong>与<font color=red>糖尿病</font>相关指南：</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=6ada41c001839005" title="中西医结合防治糖尿病足中国专家共识（第1版）" target=_blank>中西医结合防治糖尿病足中国专家共识（第1版）</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=663841c00183a81d" title="2019 WMS临床实践指南：糖尿病的管理" target=_blank>2019 WMS临床实践指南：糖尿病的管理</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=ae0501c00183a41b" title="《2019年欧洲心脏病学会和欧洲糖尿病研究学会糖尿病管理指南》解读" target=_blank>《2019年欧洲心脏病学会和欧洲糖尿病研究学会糖尿病管理指南》解读</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=32ff91c001828880" title="2019 临床建议：糖尿病护理中动态血糖曲线的应用" target=_blank>2019 临床建议：糖尿病护理中动态血糖曲线的应用</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=193281c001818193" title="治疗糖尿病药物及生物制品临床试验指导原则" target=_blank>治疗糖尿病药物及生物制品临床试验指导原则</a></li> 更多信息请点击：<a href="https://www.medsci.cn/guideline/list.do?q=%E7%B3%96%E5%B0%BF%E7%97%85" target=_blank>有关糖尿病更多指南</a></ul>, tagList=[TagDto(tagId=2052, tagName=2型糖尿病), TagDto(tagId=2664, tagName=高血糖)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=8, categoryName=糖尿病, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=10484, appHits=901, showAppHits=35, pcHits=5826, showPcHits=5409, likes=114, shares=30, comments=9, approvalStatus=1, publishedTime=Fri Dec 27 00:03:50 CST 2019, publishedTimeString=2019-12-19, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Fri Dec 27 00:03:50 CST 2019, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 19:45:06 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 ADA/EASD共识：2型糖尿病患者高血糖的管理（更新版）)])
2019 ADA/EASD共识：2型糖尿病患者高血糖的管理（更新版）
下载请点击：
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=925692, encodeId=a01992569241, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa782569271, createdName=1257d324m68暂无昵称, createdTime=Sat Feb 20 07:50:43 CST 2021, time=2021-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911945, encodeId=0efc91194526, content=收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e91c5392732, createdName=ms1000001278017290, createdTime=Tue Dec 29 17:40:22 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911499, encodeId=99329114995e, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0835081881, createdName=145b5317m51暂无昵称, createdTime=Mon Dec 28 01:02:36 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898533, encodeId=4ad989853379, content=挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4821463349, createdName=756220516, createdTime=Wed Nov 11 17:54:21 CST 2020, time=2020-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814730, encodeId=7fde814e30d0, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IyksDbh8vMS9p0LV2Ow2sfNBRpwtssHBUv4UO8iaQHibGeCHIpmFC86mzlfhXPzyT3C7ibtB3shibVdIOhLp3Ntdtw/132, createdBy=ca775362862, createdName=ms7953510254578209, createdTime=Fri Aug 28 14:16:24 CST 2020, time=2020-08-28, status=1, ipAttribution=)]
    2021-02-20 1257d324m68暂无昵称

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=925692, encodeId=a01992569241, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa782569271, createdName=1257d324m68暂无昵称, createdTime=Sat Feb 20 07:50:43 CST 2021, time=2021-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911945, encodeId=0efc91194526, content=收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e91c5392732, createdName=ms1000001278017290, createdTime=Tue Dec 29 17:40:22 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911499, encodeId=99329114995e, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0835081881, createdName=145b5317m51暂无昵称, createdTime=Mon Dec 28 01:02:36 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898533, encodeId=4ad989853379, content=挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4821463349, createdName=756220516, createdTime=Wed Nov 11 17:54:21 CST 2020, time=2020-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814730, encodeId=7fde814e30d0, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IyksDbh8vMS9p0LV2Ow2sfNBRpwtssHBUv4UO8iaQHibGeCHIpmFC86mzlfhXPzyT3C7ibtB3shibVdIOhLp3Ntdtw/132, createdBy=ca775362862, createdName=ms7953510254578209, createdTime=Fri Aug 28 14:16:24 CST 2020, time=2020-08-28, status=1, ipAttribution=)]
    2020-12-29 ms1000001278017290

    收藏

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=925692, encodeId=a01992569241, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa782569271, createdName=1257d324m68暂无昵称, createdTime=Sat Feb 20 07:50:43 CST 2021, time=2021-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911945, encodeId=0efc91194526, content=收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e91c5392732, createdName=ms1000001278017290, createdTime=Tue Dec 29 17:40:22 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911499, encodeId=99329114995e, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0835081881, createdName=145b5317m51暂无昵称, createdTime=Mon Dec 28 01:02:36 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898533, encodeId=4ad989853379, content=挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4821463349, createdName=756220516, createdTime=Wed Nov 11 17:54:21 CST 2020, time=2020-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814730, encodeId=7fde814e30d0, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IyksDbh8vMS9p0LV2Ow2sfNBRpwtssHBUv4UO8iaQHibGeCHIpmFC86mzlfhXPzyT3C7ibtB3shibVdIOhLp3Ntdtw/132, createdBy=ca775362862, createdName=ms7953510254578209, createdTime=Fri Aug 28 14:16:24 CST 2020, time=2020-08-28, status=1, ipAttribution=)]
    2020-12-28 145b5317m51暂无昵称

    不错

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=925692, encodeId=a01992569241, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa782569271, createdName=1257d324m68暂无昵称, createdTime=Sat Feb 20 07:50:43 CST 2021, time=2021-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911945, encodeId=0efc91194526, content=收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e91c5392732, createdName=ms1000001278017290, createdTime=Tue Dec 29 17:40:22 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911499, encodeId=99329114995e, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0835081881, createdName=145b5317m51暂无昵称, createdTime=Mon Dec 28 01:02:36 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898533, encodeId=4ad989853379, content=挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4821463349, createdName=756220516, createdTime=Wed Nov 11 17:54:21 CST 2020, time=2020-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814730, encodeId=7fde814e30d0, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IyksDbh8vMS9p0LV2Ow2sfNBRpwtssHBUv4UO8iaQHibGeCHIpmFC86mzlfhXPzyT3C7ibtB3shibVdIOhLp3Ntdtw/132, createdBy=ca775362862, createdName=ms7953510254578209, createdTime=Fri Aug 28 14:16:24 CST 2020, time=2020-08-28, status=1, ipAttribution=)]
    2020-11-11 756220516

    挺好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=925692, encodeId=a01992569241, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa782569271, createdName=1257d324m68暂无昵称, createdTime=Sat Feb 20 07:50:43 CST 2021, time=2021-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911945, encodeId=0efc91194526, content=收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e91c5392732, createdName=ms1000001278017290, createdTime=Tue Dec 29 17:40:22 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911499, encodeId=99329114995e, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0835081881, createdName=145b5317m51暂无昵称, createdTime=Mon Dec 28 01:02:36 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898533, encodeId=4ad989853379, content=挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4821463349, createdName=756220516, createdTime=Wed Nov 11 17:54:21 CST 2020, time=2020-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814730, encodeId=7fde814e30d0, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IyksDbh8vMS9p0LV2Ow2sfNBRpwtssHBUv4UO8iaQHibGeCHIpmFC86mzlfhXPzyT3C7ibtB3shibVdIOhLp3Ntdtw/132, createdBy=ca775362862, createdName=ms7953510254578209, createdTime=Fri Aug 28 14:16:24 CST 2020, time=2020-08-28, status=1, ipAttribution=)]
    2020-08-28 ms7953510254578209

    不错

    0

相关指南

2019 南亚工作组共识建议：应用胰高血糖素样肽-1受体激动剂 (GLP-1 RAs)治疗2型糖尿病

国外内分泌相关专家小组（统称） · 2019-07-29

中国成人2型糖尿病口服降糖药联合治疗专家共识

中华医学会内分泌学分会(CSE,Chinese Society of Endocrinology) · 2019-03-03

2019 AHA/HFSA科学声明：2型糖尿病和心衰

美国心脏协会(AHA,American Heart Association) · 2019-06-06

生酮饮食干预2型糖尿病中国专家共识（2019年版）

中国内分泌相关专家小组（统称） · 2019-03-15

2019 AACE/ACE共识声明：2型糖尿病综合管理方案

美国临床内分泌医师学会(AACE,American Association of Clinical Endocrinologists) · 2019-01-25

2018 ACC专家共识：降低2型糖尿病以及粥样硬化性心血管疾病患者心血管风险的新型治疗决策路径

美国心脏病学会(ACC,American College of Cardiology) · 2018-11-26